Figure 4
From: Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastases
Patient no. 2 in Table 4 with multiple melanoma metastasis at the right leg after two courses of limb perfusion and chemotherapy with vindesine before therapy (A) and after 57 weeks treatment, in which each metastasis was individually injected (B). In some lesions the response was assessed by histopathology; only residual pigment deposits in the dermis are visible. The patient is under CR to date, currently stable without treatment since 18 months.
